Eli Lilly Moves To Toss Zyprexa Battle With Conn.

By Anne Urda

Law360, New York (June 08, 2009, 12:00 AM ET) -- Eli Lilly and Co. has asked for summary judgment in a product liability suit over Zyprexa brought by the state of Connecticut, arguing that the state is unfairly demanding hundred of millions of dollars in refunds while continuing to recommend and promote the antipyschotic to its citizens.

The drugmaker filed a motion for summary judgment and an accompanying memorandum of law Friday in the U.S. District Court for the Eastern District of New York, contending that the state's claims about metabolic risks and off-label prescribing are...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles